Bioinformatic analysis of differentially expressed genes in muscle atrophy tissues after spinal cord injury

HUANG Weiyan; ZHANG Wenqing; ZHENG Shihao

doi:10.7619/jcmp.20201641

Journal of Clinical Medicine in Practice > 2021 > 25(4): 1-6. > DOI: 10.7619/jcmp.20201641

HUANG Weiyan, ZHANG Wenqing, ZHENG Shihao. Bioinformatic analysis of differentially expressed genes in muscle atrophy tissues after spinal cord injury[J]. Journal of Clinical Medicine in Practice, 2021, 25(4): 1-6. DOI: 10.7619/jcmp.20201641

Citation:

PDF (2633 KB)

Bioinformatic analysis of differentially expressed genes in muscle atrophy tissues after spinal cord injury

1.
College of Integrated Chinese and Western Medicine of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, 350122
2.
Department of Neurosurgery, Fujian Provincial Hospital, Fuzhou, Fujian, 350001

More Information

Received Date: January 20, 2020
Available Online: March 14, 2021
Published Date: February 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To analyze the differentially expressed genes in muscular tissue of patients with muscle atrophy after spinal cord injury by bioinformatic analysis, and the genes related to the disease were screened out.
Methods The GSE21497 chip from Gene Expression Omnibus (GEO) was selected and the differential genes were screened by R language software. The screened differentially expressed genes were analyzed by GO and KEGG, and the protein interaction network was constructed. Molecular Complex Detection Algorithm (MCODE) was used to screen for significantly differentially expressed genes with close interactions.
Results A total of 294 differentially expressed genes were screened, including 8 up-regulated genes and 286 down-regulated genes. In GO enrichment analysis, differential genes mainly existed in the structure of myosin complex, myosin complex and myosin complex, involved the binding of muscle composition and combination of β-catenin, heat shock protein and other substances, and mainly involved in muscle phylogeny, regulation of cell differentiation and apoptosis, synaptic pruning and other processes. Totally 18 differentially expressed genes that might be closely related to the occurrence and development of muscle atrophy after spinal cord injury were screened through the Protein Protein Interaction Network (PPI Network), including TNNI1, GYS1, C1QA and so on.
Conclusion The differentially expressed genes screened in this study can provide a new way to further explore the mechanism and treatment of muscle atrophy after spinal cord injury.

FullText(HTML)

References (44)

References

[1]	AHUJA C S, WILSON J R, NORI S, et al. Traumatic spinal cord injury[J]. Nat Rev Dis Primers, 2017, 3: 17018. doi: 10.1038/nrdp.2017.18
[2]	NEW P W, BIERING-SØRENSEN F. Review of the history of non-traumatic spinal cord dysfunction[J]. Top Spinal Cord Inj Rehabil, 2017, 23(4): 285-298. doi: 10.1310/sci2304-285
[3]	GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18(1): 56-87. doi: 10.1016/S1474-4422(18)30415-0
[4]	EBERT SM, AL-ZOUGBI A, BODINE SC, et al. Skeletal Muscle Atrophy: Discovery of Mechanisms and Potential Therapies[J]. Physiology (Bethesda). 2019 Jul 1; 34(4): 232-239.
[5]	HYATT H, DEMINICE R, YOSHIHARA T, et al. Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: a review of the causes and effects[J]. Arch Biochem Biophys, 2019, 662: 49-60. doi: 10.1016/j.abb.2018.11.005
[6]	GORGEY A S, KHALIL R E, LESTER R M, et al. Paradigms of lower extremity electrical stimulation training after spinal cord injury[J]. J Vis Exp, 2018(132): 57000. http://europepmc.org/abstract/MED/29443103
[7]	CASTRO M J, APPLE D F, HILLEGASS E A, et al. Influence of complete spinal cord injury on skeletal muscle cross-sectional area within the first 6 months of injury[J]. Eur J Appl Physiol Occup Physiol, 1999, 80(4): 373-378. doi: 10.1007/s004210050606
[8]	SALTZSTEIN R J, HARDIN S, HASTINGS J. Osteoporosis in spinal cord injury: using an index of mobility and its relationship to bone density[J]. J Am Paraplegia Soc, 1992, 15(4): 232-234. doi: 10.1080/01952307.1992.11761524
[9]	NOMURA T, KAWAE T, KATAOKA H, et al. Assessment of lower extremity muscle mass, muscle strength, and exercise therapy in elderly patients with diabetes mellitus[J]. Environ Health Prev Med, 2018, 23(1): 20. doi: 10.1186/s12199-018-0710-7
[10]	ITOH M, ENDO M Y, HOJO T, et al. Characteristics of cardiovascular responses to an orthostatic challenge in trained spinal cord-injured individuals[J]. J Physiol Anthropol, 2018, 37(1): 22. doi: 10.1186/s40101-018-0182-x
[11]	SASAKI K I, MATSUSE H, AKIMOTO R, et al. Cardiac cycle-synchronized electrical muscle Stimulator for lower limb training with the potential to reduce the heart's pumping workload[J]. PLoS One, 2017, 12(11): e0187395. doi: 10.1371/journal.pone.0187395
[12]	CHEN Z, LI L, XU S N, et al. A Cdh1-FoxM1-Apc axis controls muscle development and regeneration[J]. Cell Death Dis, 2020, 11(3): 180. doi: 10.1038/s41419-020-2375-6
[13]	CRISTOFANI R, RUSMINI P, GALBIATI M, et al. The regulation of the small heat shock protein B8 in misfolding protein diseases causing motoneuronal and muscle cell death[J]. Front Neurosci, 2019, 13: 796. doi: 10.3389/fnins.2019.00796
[14]	ZHANG C C, WANG C X, LI Y L, et al. Complement C3a signaling facilitates skeletal muscle regeneration by regulating monocyte function and trafficking[J]. Nat Commun, 2017, 8(1): 2078. doi: 10.1038/s41467-017-01526-z
[15]	LINK W. Introduction to FOXO biology[J]. Methods Mol Biol, 2019, 1890: 1-9. doi: 10.1007/978-1-4939-8900-3_1
[16]	BROCCA L, TONIOLO L, REGGIANI C, et al. FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension[J]. J Physiol, 2017, 595(4): 1143-1158. doi: 10.1113/JP273097
[17]	MILAN G, ROMANELLO V, PESCATORE F, et al. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy[J]. Nat Commun, 2015, 6: 6670. doi: 10.1038/ncomms7670
[18]	NINFALI C, SILES L, DARLING D S, et al. Regulation of muscle atrophy-related genes by the opposing transcriptional activities of ZEB1/CtBP and FOXO3[J]. Nucleic Acids Res, 2018, 46(20): 10697-10708. http://www.researchgate.net/publication/328250385_Regulation_of_muscle_atrophy-related_genes_by_the_opposing_transcriptional_activities_of_ZEB1CtBP_and_FOXO3/download
[19]	ABDULLAH M, KORNEGAY J N, HONCOOP A, et al. Non-targeted metabolomics analysis of golden retriever muscular dystrophy-affected muscles reveals alterations in arginine and proline metabolism, and elevations in glutamic and oleic acid in vivo[J]. Metabolites, 2017, 7(3): E38. doi: 10.3390/metabo7030038
[20]	SHENG J J, JIN J P. TNNI1, TNNI2 and TNNI3: Evolution, regulation, and protein structure-function relationships[J]. Gene, 2016, 576(1 Pt 3): 385-394. doi: 10.1016/j.gene.2015.10.052
[21]	LAMBOLEY C R, WYCKELSMA V L, PERRY BD, et al. Effect of 23-day muscle disuse on sarcoplasmic reticulum Ca²⁺ properties and contractility in human type I and type II skeletal muscle fibers[J]. J Appl Physiol (1985), 2016, 121(2): 483-492. doi: 10.1152/japplphysiol.00337.2016
[22]	CAO T, THONGAM U, JIN J P. Invertebrate troponin: Insights into the evolution and regulation of striated muscle contraction[J]. Arch Biochem Biophys, 2019, 666: 40-45. doi: 10.1016/j.abb.2019.03.013
[23]	XIROUCHAKI C E, MANGIAFICO S P, BATE K, et al. Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1(gys1) deletion in adult mice[J]. Mol Metab, 2016, 5(3): 221-232. doi: 10.1016/j.molmet.2016.01.004
[24]	DE JONGE R R, VAN SCHAIK I N, VREIJLING J P, et al. Expression of complement components in the peripheral nervous system[J]. Hum Mol Genet, 2004, 13(3): 295-302. http://hmg.oxfordjournals.org/content/13/3/295.full
[25]	MCGONIGAL R, CUNNINGHAM M E, YAO D G, et al. C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy[J]. Acta Neuropathol Commun, 2016, 4: 23. doi: 10.1186/s40478-016-0291-x
[26]	LI G S, LI Q F, DONG M M, et al. Complement components of nerve regeneration conditioned fluid influence the microenvironment of nerve regeneration[J]. Neural Regen Res, 2016, 11(4): 682-686. doi: 10.4103/1673-5374.180758
[27]	HODGE B A, ZHANG X P, GUTIERREZ-MONREAL M A, et al. MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle[J]. Elife, 2019, 8: e43017. doi: 10.7554/eLife.43017
[28]	JENDELOVA P. Therapeutic Strategies for Spinal Cord Injury[J]. International Journal of Molecular Sciences, 2018, 19(10): 3200. doi: 10.3390/ijms19103200
[29]	KAKABADZE Z, KIPSHIDZE N, MARDALEISHVILI K, et al. Phase 1 trial of autologous bone marrow stem cell transplantation in patients with spinal cord injury[J]. Stem Cells Int, 2016, 2016: 6768274. http://europepmc.org/articles/PMC4940566/
[30]	MOORE P D, GORGEY A S, WADE R C, et al. Neuromuscular electrical stimulation and testosterone did not influence heterotopic ossification size after spinal cord injury: a case series[J]. World J Clin Cases, 2016, 4(7): 172-176. doi: 10.12998/wjcc.v4.i7.172
[31]	KODANI A, KIKUCHI T, TOHDA C. Acteoside improves muscle atrophy and motor function by inducing new myokine secretion in chronic spinal cord injury[J]. J Neurotrauma, 2019, 36(12): 1935-1948. doi: 10.1089/neu.2018.6000
[32]	AHUJA C S, MARTIN A R, FEHLINGS M. Recent advances in managing a spinal cord injury secondary to trauma[J]. F1000Res, 2016, 5: F1000 Faculty Rev-1017. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890313/
[33]	TANAKA C, TAGAMI T, KANEKO J, et al. Early versus late surgery after cervical spinal cord injury: a Japanese nationwide trauma database study[J]. J Orthop Surg Res, 2019, 14(1): 302. doi: 10.1186/s13018-019-1341-4
[34]	ROSENBERG L J, TENG Y D, WRATHALL J R. Effects of the sodium channel blocker tetrodotoxin on acute white matter pathology after experimental contusive spinal cord injury[J]. J Neurosci, 1999, 19(14): 6122-6133. doi: 10.1523/JNEUROSCI.19-14-06122.1999
[35]	KAPTANOGLU E, SOLAROGLU I, SURUCU H S, et al. Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury[J]. Acta Neurochir (Wien), 2005, 147(4): 405-412. doi: 10.1007/s00701-004-0447-5
[36]	LI J, GUO W C, XIONG M, et al. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury[J]. Int J Mol Med, 2015, 36(5): 1205-1214. doi: 10.3892/ijmm.2015.2344
[37]	KUCIA M, JANKOWSKI K, RECA R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion[J]. J Mol Histol, 2004, 35(3): 233-245. http://www.tandfonline.com/servlet/linkout?suffix=CIT0086&dbid=16&doi=10.3109%2F09553002.2014.906766&key=10.1023%2FB%3AHIJO.0000032355.66152.b8
[38]	FEHLINGS M G, TETREAULT L A, WILSON J R, et al. A clinical practice guideline for the management of acute spinal cord injury: introduction, rationale, and scope[J]. Global Spine J, 2017, 7(3 Suppl): 84S-94S. http://europepmc.org/articles/PMC5684846/
[39]	EVANIEW N, BELLEY-CÔTÉ E P, FALLAH N, et al. Methylprednisolone for the treatment of patients with acute spinal cord injuries: a systematic review and meta-analysis[J]. J Neurotrauma, 2016, 33(5): 468-481. doi: 10.1089/neu.2015.4192
[40]	FEHLINGS M G, WILSON J R, HARROP J S, et al. Efficacy and safety of methylprednisolone sodium succinate in acute spinal cord injury: a systematic review[J]. Global Spine J, 2017, 7(3 Suppl): 116S-137S. http://europepmc.org/articles/PMC5684849/
[41]	CABRERA-ALDANA E E, RUELAS F, ARANDA C, et al. Methylprednisolone administration following spinal cord injury reduces aquaporin 4 expression and exacerbates edema[J]. Mediators Inflamm, 2017, 2017: 4792932.
[42]	GAZDIC M, VOLAREVIC V, HARRELL C R, et al. Stem cells therapy for spinal cord injury[J]. Int J Mol Sci, 2018, 19(4): E1039. doi: 10.3390/ijms19041039
[43]	NAGOSHI N, TSUJI O, NAKAMURA M, et al. Cell therapy for spinal cord injury using induced pluripotent stem cells[J]. Regen Ther, 2019, 11: 75-80. doi: 10.1016/j.reth.2019.05.006
[44]	JEONG S K, CHOI I, JEON S R. Current status and future strategies to treat spinal cord injury with adult stem cells[J]. J Korean Neurosurg Soc, 2020, 63(2): 153-162. doi: 10.3340/jkns.2019.0146

Cited By

Get Citation

PDF

XML

Article views (483) PDF downloads (37)

Turn off MathJax

Article Contents

Abstract

References

Bioinformatic analysis of differentially expressed genes in muscle atrophy tissues after spinal cord injury

Abstract

References

Catalog

Export File

Citation

Format

Content